The short version
Only one company currently supplies this market — there is no backup if it stumbles. The price has fallen 43% in a year, to $5.51 per unit — and generics that get this cheap tend to get abandoned rather than defended.
Market view
apixaban · Kit
1 marketed package NDCs · 1 active manufacturer
Most dispensed: 5 mg · Tablet, Film Coated · #60 tablet, film coateds/bottle, plastic · 2.5 mg · Tablet, Film Coated · #10 blister packs/carton / 10 tablet, film coated in 1 blister pack · 5 mg · Tablet, Film Coated · #10 blister packs/carton / 10 tablet, film coated in 1 blister pack · 2.5 mg · Tablet, Film Coated · #60 tablet, film coateds/bottle, plastic
Price range and competition
RSS: changes for this drugEvery company selling this drug reports its own price. The line follows the middle of the pack; the shaded band holds the middle half of companies — the wider it is, the more they disagree.
Latest · Sep 2026 — typical price $5.51 · middle half $5.51–$5.51 · full range $5.51–$5.51 · 1 products · 1 companies
ⓘ How this was built
Data sources
- CMS NADAC weekly survey + monthly archives back to 2013 (data.medicaid.gov)
- CMS Federal Upper Limit files (weighted AMP)
- FDA NDC Directory (openFDA) — maker roster
Method
Each month's band spans the NADAC unit prices of every NDC of this drug (min, quartiles, median, max), split into brand and generic cohorts by FDA marketing category. Maker counts come from distinct labelers with the NDC actively listed.
Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.
What changed in the last 90 days
Every detected change for apixaban, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.
- ELIQUIS 30-Day Starter PackAug 19, 2026Price upNADAC $5.50588 → $5.50609 per unit (0%)
- EliquisAug 19, 2026Price downNADAC $5.52277 → $5.52106 per unit (-0.03%)
- EliquisAug 19, 2026Price downNADAC $5.52277 → $5.52106 per unit (-0.03%)
- EliquisAug 19, 2026Price downNADAC $5.52277 → $5.52106 per unit (-0.03%)
- EliquisAug 19, 2026Price upNADAC $5.51491 → $5.51857 per unit (+0.07%)
- EliquisAug 19, 2026Price upNADAC $5.51491 → $5.51857 per unit (+0.07%)
- apixabanJul 23, 2026Mfr enteredPharmacia & Upjohn Company LLC · apixaban
- apixabanJul 23, 2026New productPharmacia & Upjohn Company LLC
- EliquisJul 22, 2026Price upNADAC $5.52276 → $5.52277 per unit (0%)
- EliquisJul 22, 2026Price downNADAC $5.51612 → $5.51491 per unit (-0.02%)
Same drug class
Other molecules FDA puts in Factor Xa Inhibitor, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.
Common questions
- Is Apixaban in shortage right now?
- No. FDA does not currently list Apixaban in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
- Who makes Apixaban?
- 50 companies have marketed Apixaban in the last 30 days, according to the FDA NDC Directory. Every manufacturer and package is listed on this page.
- What does Apixaban cost?
- The typical pharmacy pays about $5.52 per unit, based on the most recent CMS NADAC survey of actual acquisition costs. That is what the pharmacy pays for the drug itself — not the cash price, and not what an insurer is billed.
All marketed products
Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.